Clinical Trial Update: Alwide Plus China Post-market Clinical Investigation

View source ↗

Summary

Post-market clinical investigation of Alwide Plus in China has completed, evaluating safety and performance in patients with severe aortic stenosis undergoing t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Alwide Plus

Snippet

Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. | Conditions: Severe Aortic Stenosis, Transcatheter Aortic Valve Replacemen | Status: COMPLETED